Back to 13F data
Healthcare

COYA THERAPEUTICS INC

COYA THERAPEUTICS INC is tracked here as a normalized 13F company record; no curated business description is available yet.

Original CUSIPs: 22407B108. This page shows current managers, quarterly changes, and primary SEC sources.

Current managers
1
Latest reporting quarter
Q1 2026

Who holds it and what changed this quarter

Portfolio weight and share-count changes are shown for every tracked manager with a current or prior-quarter position.

Greenlight Capital
David Einhorn
Q1 2026
Increased
0.41% 0.29%

Greenlight Capital added 309,600 shares; portfolio weight moved from 0.41% to 0.29%.

+309,600 Shares
+15.28%
SEC05/15/2026

Four-quarter trend

Each line is one tracked manager’s portfolio weight. Labels identify the manager directly.

Historical and source details

Market values, quarterly totals, and original CUSIP rows are available below without obscuring current actions.

Quarterly holdings details
QuarterCurrent managersCombined valueTotal sharesManager details
Q2 20251$9,467,0301,646,440
Greenlight Capital New position · 1,646,440 Shares
Q3 20251$9,384,7081,646,440
Greenlight Capital Unchanged · 1,646,440 Shares
Q4 20251$11,750,4522,025,940
Greenlight Capital Increased · 2,025,940 Shares
Q1 20261$9,202,0272,335,540
Greenlight Capital Increased · 2,335,540 Shares
Original CUSIP details
ManagerIssuerCUSIPSecurity classMarket valueSharesWeightSource
Greenlight CapitalCOYA THERAPEUTICS INC22407B108COMMON STOCK$9,202,0272,335,5400.29%SEC XML